HRS-8829
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
Safety, Tolerability and Pharmacokinetic Study of HRS-8829
(clinicaltrials.gov)
- P1 | N=70 | Not yet recruiting | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
New P1 trial • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1